Full text biomedical articles

Efficiency of Ipratropium Bromide and Albuterol Deposition in the Lung Delivered via a Soft Mist Inhaler or Chlorofluorocarbon Metered‐Dose Inhaler

TR MacGregor, R ZuWallack, V Rubano, MA Castles, H Dewberry, M Ghafouri, CC Wood
Clin Transl Sci. 2016 Apr; 9(2): 105–113. Published online 2016 Mar 6. doi: 10.1111/cts.12387


Article   |   PubReader   |   PDF–409K   |   Cite

Inhaled magnesium sulfate in the treatment of acute asthma

Rachel Knightly, Stephen J Milan, Rodney Hughes, Jennifer A Knopp‐Sihota, Brian H Rowe, Rebecca Normansell, Colin Powell, Cochrane Airways Group
Cochrane Database Syst Rev. 2017 Nov; 2017(11): CD003898. Published online 2017 Nov 28. doi: 10.1002/14651858.CD003898.pub6


Article   |   PubReader   |   PDF–1.0M   |   Cite

Responsiveness to Ipratropium Bromide in Male and Female Patients with Mild to Moderate Chronic Obstructive Pulmonary Disease

Xuan Li, Ma'en Obeidat, Guohai Zhou, Janice M. Leung, Donald Tashkin, Robert Wise, John Connett, Philippe Joubert, Yohan Bossé, Maarten van den Berge, Corry-Anke Brandsma, David C. Nickle, Ke Hao, Peter D. Paré, Don D. Sin
EBioMedicine. 2017 May; 19: 139–145. Published online 2017 Apr 12. doi: 10.1016/j.ebiom.2017.04.020


Article   |   PubReader   |   PDF–626K   |   Cite

Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials

Sarah Haney, Robert J Hancox
Respir Res. 2007; 8(1): 19. Published online 2007 Mar 6. doi: 10.1186/1465-9921-8-19


Article   |   PubReader   |   PDF–288K   |   Cite

Sequential comparison of tiotropium to high-dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting

Umair Gauhar, Mark Dransfield, J Allen D Cooper
Int J Chron Obstruct Pulmon Dis. 2009; 4: 391–395. Published online 2009 Oct 19. doi: 10.2147/copd.s7566


Article   |   PubReader   |   PDF–159K   |   Cite

The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China

Kewu Huang, Yanfei Guo, Jian Kang, Li An, Zeguang Zheng, Lijun Ma, Liping Peng, Hongyang Wang, Rong Su, Yohji Itoh, Chen Wang
Ther Adv Respir Dis. 2019 Jan-Dec; 13: 1753466619853500. Published online 2019 Jun 26. doi: 10.1177/1753466619853500


Article   |   PubReader   |   PDF–934K   |   Cite

Nebulized Ipratropium bromide protects against tracheal and bronchial secretion during bronchoscopy: A randomized controlled trial

Faping Wang, He Zheng, Yanlin Zhang, Hui Zhu, Jingyu Shi, Yunxiao Luo, Xiang Zhang, Hui Mao, Felix J.F. Herth, Fengming Luo
Medicine (Baltimore) 2019 Nov; 98(47): e17942. Published online 2019 Nov 22. doi: 10.1097/MD.0000000000017942


Article   |   PubReader   |   PDF–413K   |   Cite

A comparison of plethysmography, spirometry and oscillometry for assessing the pulmonary effects of inhaled ipratropium bromide in healthy subjects and patients with asthma

C M Houghton, A A Woodcock, D Singh
Br J Clin Pharmacol. 2005 Feb; 59(2): 152–159. doi: 10.1111/j.1365-2125.2004.02262.x


Article   |   PubReader   |   PDF–119K   |   Cite

A Comparative Study of the Beneficial Effects of Ipratropium and Beclomethasone against Insulin-Induced Tracheal Tissue Contraction in a Guinea Pig Model

Mahjabeen Sharif, Bushra Tayyaba Khan, Shoaib Bin Aleem, Mohammad Asim Anwar
Med Princ Pract. 2015 Jan; 24(1): 92–95. Published online 2014 Sep 24. doi: 10.1159/000366259


Article   |   PubReader   |   PDF–405K   |   Cite

Effects of ipratropium bromide on the occurrence of postoperative respiratory complications in craniectomy patients with COPD: A nationwide multicenter retrospective study

Zhuoying Du, Xiaoqian Huang, Yi Feng, Wei Yan, Dan Xu, Xiaoou Sun, Chao Wu, Yongke Zheng, Longhuan Zeng, Xiaowei Xiong, Yuankun Liu, Chenbo Zhang, Jianfeng Luo, Jin Hu
Medicine (Baltimore) 2020 Jun 26; 99(26): e20836. Published online 2020 Jun 26. doi: 10.1097/MD.0000000000020836


Article   |   PubReader   |   PDF–250K   |   Cite

Ipratropium bromide versus long‐acting beta‐2 agonists for stable chronic obstructive pulmonary disease

Cochrane Database Syst Rev. 2006 Jul; 2006(3): CD006101. Published online 2006 Jul 19. doi: 10.1002/14651858.CD006101


Article   |   PubReader   |   PDF–531K   |   Cite

Ipratropium bromide versus short acting beta‐2 agonists for stable chronic obstructive pulmonary disease

Sarah Appleton, Terry Jones, Phillippa Poole, Louis Pilotto, Robert Adams, Toby J Lasserson, Brian J Smith, Julia Muhammed, Cochrane Airways Group
Cochrane Database Syst Rev. 2006 Apr; 2006(2): CD001387. Published online 2006 Apr 19. doi: 10.1002/14651858.CD001387.pub2


Article   |   PubReader   |   PDF–565K   |   Cite

Bronchodilator effects of ipratropium bromide and albuterol sulfate among subjects with tetraplegia

Gregory J. Schilero, Joshua C. Hobson, Kamaldeep Singh, Ann M. Spungen, William A. Bauman, Miroslav Radulovic
J Spinal Cord Med. 2018 Jan; 41(1): 42–47. Published online 2016 Nov 3. doi: 10.1080/10790268.2016.1235753


Article   |   PubReader   |   PDF–267K   |   Cite

Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD

Amal Bhattacharya, Salil Bhargava, Virendra Singh, Deepak Talwar, Jagdeep Whig, Juliet Rebello, Shrinivas Purandare, Jaideep Gogtay
Int J Chron Obstruct Pulmon Dis. 2016; 11: 1469–1476. Published online 2016 Jun 30. doi: 10.2147/COPD.S89923


Article   |   PubReader   |   PDF–356K   |   Cite

Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain

Maureen P. M. H. Rutten-van Mölken, Jan B. Oostenbrink, Marc Miravitlles, Brigitta U. Monz
Eur J Health Econ. 2007 Jun; 8(2): 123–135. Published online 2007 Mar 17. doi: 10.1007/s10198-007-0039-4


Article   |   PubReader   |   PDF–331K   |   Cite

Factors Affecting the Stability and Performance of Ipratropium Bromide; Fenoterol Hydrobromide Pressurized-Metered Dose Inhalers

Jenjira Ninbovorl, Somchai Sawatdee, Teerapol Srichana
AAPS PharmSciTech. 2013 Dec; 14(4): 1294–1302. Published online 2013 Aug 23. doi: 10.1208/s12249-013-0024-4


Article   |   PubReader   |   PDF–263K   |   Cite

COPD patient satisfaction with ipratropium bromide/albuterol delivered via Respimat: a randomized, controlled study

Gary T Ferguson, Mo Ghafouri, Luyan Dai, Leonard J Dunn
Int J Chron Obstruct Pulmon Dis. 2013; 8: 139–150. Published online 2013 Mar 19. doi: 10.2147/COPD.S38577


Article   |   PubReader   |   PDF–317K   |   Cite

Reversed phase-high performance liquid chromatographic method to measure migration of semivolatile compound, vanillin, in ipratropium bromide inhalation solution

Dennis Conkins, Julia E Economou, James A Boersma, Mehendra G Dedhiya, Gordon Hansen
AAPS PharmSci. 1999 Sep; 1(3): 66–69. Published online 1999 Sep 21. doi: 10.1208/ps010315


Article   |   PubReader   |   PDF–347K   |   Cite

Supraventricular tachycardia caused by nebulised ipratropium bromide.

B R O'Driscoll
Thorax. 1989 Apr; 44(4): 312. doi: 10.1136/thx.44.4.312


Summary   |   Page Browse   |   PDF–154K   |   Cite

Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial

James F. Donohue, Robert Wise, William W. Busse, Sandra Garfinkel, Valentina B. Zubek, Mo Ghafouri, Raymond C. Manuel, Rozsa Schlenker-Herceg, Eugene R. Bleecker
BMC Pulm Med. 2016; 16: 65. Published online 2016 Apr 30. doi: 10.1186/s12890-016-0223-3


Article   |   PubReader   |   PDF–1.3M   |   Cite